Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05182229 · ClinicalTrials.gov registry record · NA
Comparing Two Ways to Manage Head and Neck Lymphedema
A NA study of Head and Neck Cancer and Lymphedema, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 6
- Study locations
NCT05182229 is a NA study of Head and Neck Cancer and Lymphedema that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 300 participants, above the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (15% higher). The trial reports 6 study locations across 2 states.
The verdict
NCT05182229, a NA study of Head and Neck Cancer and Lymphedema, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 6
- Study locations
Study Summary
This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
Conditions Studied
Interventions
- OTHER Home-based (a hybrid model) CDT
- OTHER Clinic-based CDT
Study Locations (6)
Pennsylvania
- University of Pennsylvania - Philadelphia
- Jefferson Health - Philadelphia
- Jefferson Torresdale Hospital Jefferson Health - Philadelphia
- Temple University Hospital and Fox Chase Cancer Center - Philadelphia
- Asplundh Cancer Pavilion Jefferson Health - Willow Grove
New Jersey
- Jefferson Cherry Hospital Jefferson Health - Cherry Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-03-11 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05182229
The ClinicalTrials.gov registry entry for NCT05182229 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 260-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (15% higher). The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Home-based (a hybrid model) CDT is the first listed.
NCT05182229 reports 6 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05182229 about?
NCT05182229 is a clinical study titled "Comparing Two Ways to Manage Head and Neck Lymphedema". This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
What is the current status of trial NCT05182229?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-03-11. Estimated completion is 2026-11-30.
What conditions does trial NCT05182229 study?
This clinical trial studies the following conditions: Head and Neck Cancer, Lymphedema.
What interventions are being tested in trial NCT05182229?
The interventions under investigation include: Home-based (a hybrid model) CDT (OTHER), Clinic-based CDT (OTHER).
Who is sponsoring clinical trial NCT05182229?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05182229 being conducted?
This trial has 6 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
Axoguard HA Plus Nerve Protector to Reduce Post-operative Neck and Shoulder Dysfunction in Patients Undergoing Neck Dissection
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.